Guru Ownership Trend
Guru Analysis for Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics, Inc. (ALLO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $8.59 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $2.75 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 113.4%. Conversely, Murray Stahl reduced exposure by 4.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Allogene Therapeutics, Inc. (ALLO)
Major holders include Cliff Asness ($6.06 M), Renaissance Technologies (RenTech) ($5.22 M), Steven Cohen ($540,057). According to the latest reported data, 5 tracked investment managers collectively hold approximately 4.94 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.75 M, with 3 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited ALLO. The total reported sell value was $118,491.27.
Yes, 0 managers opened new positions in ALLO, and 3 increased their existing holdings. The total reported buy value was $2.87 M.